Pinkerton Retirement Specialists’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
AIM
ACG
NAMA
Pinkerton Retirement Specialists's DNA Position: Q4 2023 in Review
Pinkerton Retirement Specialists sold out of Ginkgo Bioworks (DNA) in Q4 2023, closing a stake of 1,047 shares — an estimated $75.8K sold.
Pinkerton Retirement Specialists first reported a position in DNA in Q3 2023 and held it in 1 quarter. The position peaked at $75.8K in Q3 2023. 342 funds tracked by Wall St. Rank hold DNA as of Q4 2023.
- Pinkerton Retirement Specialists reported no remaining Ginkgo Bioworks position as of Q4 2023 after selling out during the quarter.
- Pinkerton Retirement Specialists sold 1,047 Ginkgo Bioworks shares in Q4 2023, an estimated $75.8K.
- Pinkerton Retirement Specialists first reported a position in Ginkgo Bioworks in Q3 2023 and held it in 1 quarter.
- Pinkerton Retirement Specialists's Ginkgo Bioworks position peaked at $75.8K in Q3 2023.
- 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2023.
Based on Pinkerton Retirement Specialists's 13F filing for Q4 2023, filed 25 Jan 2024.